Clinical Trial Update: Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 trial evaluating pegaptanib sodium vs sham injections for vision loss due to macular edema from central retinal vein occlusion, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Eyetech Pharmaceuticals | Conditions: Retinal Vein Occlusion | Phase 2 | Status: COMPLETED